132 related articles for article (PubMed ID: 9893666)
1. Targeted cancer chemotherapy for VX2 tumour implanted in the colon with lipiodol as a carrier.
Nagamitsu A; Konno T; Oda T; Tabaru K; Ishimaru Y; Kitamura N
Eur J Cancer; 1998 Oct; 34(11):1764-9. PubMed ID: 9893666
[TBL] [Abstract][Full Text] [Related]
2. Treatment of VX2 carcinoma implanted in the liver with arterial and intraperitoneal administration of oily anticancer agents.
Tabaru K; Konno T; Oda T; Nagamitsu A; Ishimaru Y; Kitamura N
Cancer Chemother Pharmacol; 2001; 47(2):149-54. PubMed ID: 11269741
[TBL] [Abstract][Full Text] [Related]
3. Targeted vinblastine chemotherapy with two preparations of lipiodol contrast medium.
Oda T; Konno T; Nagamitsu A; Tabaru K; Maeda H; Kitamura N
Anticancer Res; 1997; 17(5A):3521-9. PubMed ID: 9413197
[TBL] [Abstract][Full Text] [Related]
4. Targeting cancer chemotherapeutic agents by use of lipiodol contrast medium.
Konno T
Cancer; 1990 Nov; 66(9):1897-903. PubMed ID: 2171752
[TBL] [Abstract][Full Text] [Related]
5. [Targeting chemotherapy of hepatocellular carcinoma by arterial administration of anticancer agents dissolved in lipiodol].
Konno T
Gan To Kagaku Ryoho; 1987 Feb; 14(2):373-80. PubMed ID: 3028275
[TBL] [Abstract][Full Text] [Related]
6. Polybutylcyanoacrylate nanoparticles as a carrier for mitomycin C in rabbits bearing VX2-liver tumor.
Xi-Xiao Y; Jan-Hai C; Shi-Ting L; Dan G; Xv-Xin Z
Regul Toxicol Pharmacol; 2006 Dec; 46(3):211-7. PubMed ID: 17010489
[TBL] [Abstract][Full Text] [Related]
7. [Targeting cancer chemotherapy using lipiodol as a carrier of anticancer drugs for hepatocellular carcinoma].
Konno T; Maeda H
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1043-50. PubMed ID: 2839112
[TBL] [Abstract][Full Text] [Related]
8. [Arterial infusion of anticancer agent and lipiodol using a totally implanted drug delivery system].
Kishimoto W; Nonami T; Nakao A; Harada A; Kuroe K; Haba T; Takagi H
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2531-4. PubMed ID: 2843118
[TBL] [Abstract][Full Text] [Related]
9. Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image.
Iwai K; Maeda H; Konno T
Cancer Res; 1984 May; 44(5):2115-21. PubMed ID: 6324996
[TBL] [Abstract][Full Text] [Related]
10. [Arterial administration of SMANCS and other antitumor agents dissolved in lipiodol for various malignant solid tumors].
Konno T; Iwai K; Maki S; Tashiro S; Miyauchi Y; Maeda H; Yokoyama I
Nihon Geka Gakkai Zasshi; 1984 Sep; 85(9):1151-6. PubMed ID: 6095018
[TBL] [Abstract][Full Text] [Related]
11. [Studies on drug release from anti-cancer drug suspended Lipiodol].
Isshiki K; Kishimoto W; Nonami T; Kato H; Haba T; Nakao A; Harada A; Takagi H; Kato M; Mizoguchi M
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3019-23. PubMed ID: 2551242
[TBL] [Abstract][Full Text] [Related]
12. [Arterial administration of oily anticancer agents dissolved in lipiodol fluid in recurrence of hepatoma after hepatic resection and in metastatic liver cancer].
Ohtsuka N; Konno T
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1351-8. PubMed ID: 2837992
[TBL] [Abstract][Full Text] [Related]
13. [Intraperitoneal chemotherapy with mitomycin C bound to activated carbon nanoparticles for nude mice bearing human gastric carcinoma].
Qu QL; Zhang YG; Yang LZ; Sun L
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):257-60. PubMed ID: 16875622
[TBL] [Abstract][Full Text] [Related]
14. [Anti-tumor activity of zinostatin stimalamer (YM 881) examined by human hepatoma cells in vitro and VX2 liver tumor in vivo].
Tanaka S; Fujihara A; Yamamoto M; Asano M; Ida H; Ohmi Y; Kitazaki T; Kikuchi Y; Yoshida S; Okamiya H
Gan To Kagaku Ryoho; 1994 Feb; 21(2):219-26. PubMed ID: 8311492
[TBL] [Abstract][Full Text] [Related]
15. Transcatheter arterial chemoembolization with paclitaxel-lipiodol solution in rabbit VX2 liver tumor.
Yoon CJ; Chung JW; Park JH; Yoon YH; Lee JW; Jeong SY; Chung H
Radiology; 2003 Oct; 229(1):126-31. PubMed ID: 12944599
[TBL] [Abstract][Full Text] [Related]
16. [Effects of transcatheter arterial chemoembolization with pingyangmycin-lipiodol emulsion on VX2 liver tumors in rabbits].
Liu X; Luo XP; Cao WT; Deng H
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):611-6. PubMed ID: 23207156
[TBL] [Abstract][Full Text] [Related]
17. Mitomycin C and lipiodol do not improve the effect of intermittent hepatic artery occlusion on liver tumour growth. An experimental study in the rat.
Sjövall S; Foss A; Audisio R; Ahrén B; Bengmark S
Anticancer Res; 1991; 11(5):1823-5. PubMed ID: 1662927
[TBL] [Abstract][Full Text] [Related]
18. Treatment of renal cell carcinoma with intra-arterial administration of SMANCS dissolved in Lipiodol.
Noda S; Konno S; Tanaka J; Yamada M; Yoshitake N
Anticancer Res; 1990; 10(3):709-15. PubMed ID: 2164351
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effects of intraarterial infusion of tumor necrosis factor/lipiodol emulsion on hepatic tumor in rabbits.
Watanabe D; Ueo H; Inoue H; Matsuoka H; Honda M; Shinomiya Y; Takamatsu T; Akiyoshi T
Oncology; 1995; 52(1):76-81. PubMed ID: 7800348
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.
Gabizon A; Amitay Y; Tzemach D; Gorin J; Shmeeda H; Zalipsky S
J Control Release; 2012 Jun; 160(2):245-53. PubMed ID: 22134116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
